Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Tacrolimus (Prograf?)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 70,368Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Chunghwa Chemical Synthesis & Biotech
    Taiwan
    		 Hwail Pharmaceutical Co., Ltd. 20140417-204-I-289-08 Tacrolimus hydrate 2014-04-17 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shanjia Plant Taiwan No.1, Tung-Hsing st., Shu-Lin, New Taipei City, Taiwan
    29/11/2025 Fishfa Biogenics
    India
    		 Toru Co., Ltd. 20251002-204-I-730-13 Tacrolimus hydrate 2025-10-02 FISHFA BIOGENICS India Survey No. 43/2/2, 47/2, 50/1/2, 50/2,Kuvadwa-Wankaner Highway, Village- Rampara (Surya), Tal- Rajkot, Dist. – Rajkot-360003, Gujarat State, India.